首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Thrombin cleaves recombinant human thrombopoietin: One of the proteolytic events that generates truncated forms of thrombopoietin
【2h】

Thrombin cleaves recombinant human thrombopoietin: One of the proteolytic events that generates truncated forms of thrombopoietin

机译:凝血酶裂解重组人血小板生成素:蛋白水解事件之一其产生截短形式的血小板生成素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A heterogeneity in the molecular weight (Mr) of thrombopoietin (TPO) has been reported. We found several thrombin cleavage sites in human, rat, murine, and canine TPOs, and also found that human TPO undergoes selective proteolysis by thrombin. Recombinant human TPO (rhTPO) was incubated with human platelets in the presence of calcium ions to allow the generation of thrombin, and was cleaved into low Mr peptide fragments. The cleavage was completely inhibited by hirudin, indicating that the proteolysis was mediated by thrombin. In a platelet-free system, analyses of thrombin cleavage by immunoblotting using anti-human TPO peptide antibodies revealed that the four major thrombin-cleaved peptide fragments were selectively generated depending on the digestion time. The amino acid sequences of the thrombin-polypeptides were further analyzed, and two major thrombin cleavage sites were determined. One of them was at AR191-T192 in the C-terminal domain of TPO, and thrombin cleaved first at this site. The other site at GR117-T118 in the N-terminal domain was subsequently cleaved by prolonged thrombin digestion. As a result, the biological activity of TPO was modulated. The generation of truncated forms of TPO by thrombin may be a notable event in view of the platelet-related metabolism of TPO.
机译:血小板生成素(TPO)的分子量(Mr)存在异质性。我们在人,大鼠,鼠和犬的TPO中发现了几个凝血酶裂解位点,并且还发现人TPO受到凝血酶的选择性蛋白水解作用。重组人TPO(rhTPO)在钙离子存在下与人血小板一起温育以产生凝血酶,然后裂解为低Mr肽片段。水hi素完全抑制了切割,表明蛋白水解是由凝血酶介导的。在无血小板系统中,使用抗人TPO肽抗体通过免疫印迹进行的凝血酶裂解分析表明,取决于消化时间,选择性地产生了四个主要的凝血酶裂解肽段。进一步分析了凝血酶多肽的氨基酸序列,并确定了两个主要的凝血酶切割位点。其中之一是在TPO C末端结构域的AR 191 -T 192 ,凝血酶首先在该位点裂解。 N-末端结构域的GR 117 -T 118 上的另一个位点随后通过长时间的凝血酶消化而被切割。结果,调节了TPO的生物学活性。鉴于血小板相关的TPO代谢,凝血酶产生的TPO截短形式可能是一个值得注意的事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号